News & Updates
Filter by Specialty:
Polysaccharide hemostatic powder shows promise for peptic ulcer bleeding
In the initial endoscopic treatment of peptic ulcer bleeding, the use of polysaccharide hemostatic powder appears to be not less efficacious than conventional treatment, according to a study.
Polysaccharide hemostatic powder shows promise for peptic ulcer bleeding
27 Mar 2023Ondansetron shows potential in irritable bowel syndrome with diarrhoea
A study on titrated ondansetron for the treatment of irritable bowel syndrome with diarrhoea (IBS-D) has fallen short of meeting the endpoint due to being underpowered. However, when data from this study and two others were pooled in a meta-analysis, ondansetron appears to yield significant improvements in the composite endpoint set by the Food and Drug Administration (FDA), namely stool consistency and urgency.
Ondansetron shows potential in irritable bowel syndrome with diarrhoea
27 Mar 20235-ASA maintenance therapy of little help in patients with newly diagnosed CD
Maintenance treatment with 5-aminosalicylates (5-ASA) in patients with newly diagnosed Crohn's disease (CD) does not appear to lead to better outcomes as compared with a watchful waiting approach, according to a study.
5-ASA maintenance therapy of little help in patients with newly diagnosed CD
23 Mar 2023Telbivudine use during pregnancy safe, effective in HBsAG-positive mothers
Use of telbivudine (LdT) during the second trimester of pregnancy helps prevent mother-to-child transmission of hepatitis B virus, reveals a study. In addition, treatment with LdT during pregnancy is safe in the long term for both mothers and infants.
Telbivudine use during pregnancy safe, effective in HBsAG-positive mothers
20 Mar 2023How accurate is PPI test in GERD, chest pain diagnosis?
Use of the proton pump inhibitor (PPI) test showed acceptable sensitivity but poor specificity in diagnosing gastroesophageal reflux disease (GERD), a study has shown. The test, however, works better in GERD-related noncardiac chest pain (NCCP).
How accurate is PPI test in GERD, chest pain diagnosis?
19 Mar 2023NEPA- and olanzapine-based regimens similarly effective at preventing CINV in early BC
In a post hoc analysis of two prospective studies, netupitant/palonosetron (NEPA) combined with dexamethasone has demonstrated similar efficacy vs a quadruplet regimen of olanzapine, aprepitant, ondansetron, and dexamethasone in preventing chemotherapy-induced nausea and vomiting (CINV) in Chinese women with early breast cancer (BC) receiving doxorubicin/cyclophosphamide (AC) in Hong Kong.